Non-thermal plasma modulates cellular markers associated with immunogenicity in a model of latent HIV-1 infection
Open Access
- 1 March 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (3), e0247125
- https://doi.org/10.1371/journal.pone.0247125
Abstract
Effective control of infection by human immunodeficiency virus type 1 (HIV-1), the causative agent of the acquired immunodeficiency syndrome (AIDS), requires continuous and life-long use of anti-retroviral therapy (ART) by people living with HIV-1 (PLWH). In the absence of ART, HIV-1 reemergence from latently infected cells is ineffectively suppressed due to suboptimal innate and cytotoxic T lymphocyte responses. However, ART-free control of HIV-1 infection may be possible if the inherent immunological deficiencies can be reversed or restored. Herein we present a novel approach for modulating the immune response to HIV-1 that involves the use of non-thermal plasma (NTP), which is an ionized gas containing various reactive oxygen and nitrogen species (RONS). J-Lat cells were used as a model of latent HIV-1 infection to assess the effects of NTP application on viral latency and the expression of pro-phagocytic and pro-chemotactic damage-associated molecular patterns (DAMPs). Exposure of J-Lat cells to NTP resulted in stimulation of HIV-1 gene expression, indicating a role in latency reversal, a necessary first step in inducing adaptive immune responses to viral antigens. This was accompanied by the release of pro-inflammatory cytokines and chemokines including interleukin-1β (IL-1β) and interferon-γ (IFN-γ); the display of pro-phagocytic markers calreticulin (CRT), heat shock proteins (HSP) 70 and 90; and a correlated increase in macrophage phagocytosis of NTP-exposed J-Lat cells. In addition, modulation of surface molecules that promote or inhibit antigen presentation was also observed, along with an altered array of displayed peptides on MHC I, further suggesting methods by which NTP may modify recognition and targeting of cells in latent HIV-1 infection. These studies represent early progress toward an effective NTP-based ex vivo immunotherapy to resolve the dysfunctions of the immune system that enable HIV-1 persistence in PLWH.Keywords
Funding Information
- German Federal Ministry of Education and Research (03Z22DN11)
- German Federal Ministry of Education and Research (03Z22DN12)
- German Federal Ministry of Education and Research (03Z22Di1)
- Drexel University College of Medicine, Department of Microbiology & Immunology and Institute for Molecular Medicine and Infectious Disease
- Drexel University Office of Global Engagement and Education Abroad
This publication has 78 references indexed in Scilit:
- Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic ReviewPLOS ONE, 2013
- Molecular signatures of T-cell inhibition in HIV-1 infectionRetrovirology, 2013
- Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible SolutionsJournal of Immunology Research, 2012
- Systemic Immune Activation in HIV Infection Is Associated with Decreased MDC Responsiveness to TLR Ligand and Inability to Activate Naive CD4 T-CellsPLOS ONE, 2011
- Effects of Non-Thermal Plasma on Mammalian CellsPLOS ONE, 2011
- HMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigenVaccine, 2010
- RETRACTED ARTICLE: Non-thermal Plasma Induces Apoptosis in Melanoma Cells via Production of Intracellular Reactive Oxygen SpeciesAnnals of Biomedical Engineering, 2010
- Monocyte Chemoattractant Protein-1 (MCP-1): An OverviewJournal of Interferon & Cytokine Research, 2009
- Impact of MHC class I diversity on immune control of immunodeficiency virus replicationNature Reviews Immunology, 2008
- HLA Alleles Associated with Slow Progression to AIDS Truly Prefer to Present HIV-1 p24PLOS ONE, 2007